| Literature DB >> 24175300 |
Anis Safura Ramli1, Aqil Mohammad Daher, Mohamed Noor Khan Nor-Ashikin, Nafiza Mat-Nasir, Kien Keat Ng, Maizatullifah Miskan, Krishnapillai S Ambigga, Farnaza Ariffin, Md Yasin Mazapuspavina, Suraya Abdul-Razak, Hasidah Abdul-Hamid, Fadhlina Abd-Majid, Najmin Abu-Bakar, Hapizah Nawawi, Khalid Yusoff.
Abstract
Metabolic syndrome (MetS) is a steering force for the cardiovascular diseases epidemic in Asia. This study aimed to compare the prevalence of MetS in Malaysian adults using NCEP-ATP III, IDF, and JIS definitions, identify the demographic factors associated with MetS, and determine the level of agreement between these definitions. The analytic sample consisted of 8,836 adults aged ≥30 years recruited at baseline in 2007-2011 from the Cardiovascular Risk Prevention Study (CRisPS), an ongoing, prospective cohort study involving 18 urban and 22 rural communities in Malaysia. JIS definition gave the highest overall prevalence (43.4%) compared to NCEP-ATP III (26.5%) and IDF (37.4%), P < 0.001. Indians had significantly higher age-adjusted prevalence compared to other ethnic groups across all MetS definitions (30.1% by NCEP-ATP III, 50.8% by IDF, and 56.5% by JIS). The likelihood of having MetS amongst the rural and urban populations was similar across all definitions. A high level of agreement between the IDF and JIS was observed (Kappa index = 0.867), while there was a lower level of agreement between the IDF and NCEP-ATP III (Kappa index = 0.580). JIS definition identified more Malaysian adults with MetS and therefore should be recommended as the preferred diagnostic criterion.Entities:
Mesh:
Year: 2013 PMID: 24175300 PMCID: PMC3794630 DOI: 10.1155/2013/760963
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Diagnostic criteria for metabolic syndrome.
| Risk factors (RF) | NCEP-ATP III (2001) | IDF (2005) | Modified NCEP-ATP III (2005) | JIS (2009) |
|---|---|---|---|---|
| Waist circumference (WC) | M ≥ 102 cm F ≥ 88 cm | M ≥ 90 cm F ≥ 80 cm | M ≥ 90 cm F ≥ 80 cm | M ≥ 90 cm F ≥ 80 cm |
| Blood pressure (BP) | Systolic BP ≥ 130 and/or diastolic BP ≥ 85 mmHg | Systolic BP ≥ 130 and/or diastolic BP ≥ 85 mmHg or on treatment for HPT | Systolic BP ≥ 130 and/or diastolic BP ≥ 85 mmHg or on treatment for HPT | Systolic BP ≥ 130 and/or diastolic BP ≥ 85 mmHg or on treatment for HPT |
| Fasting plasma glucose (FPG) | ≥6.1 mmol/L | ≥5.6 mmol/L or previously diagnosed T2DM | ≥5.6 mmol/L or on treatment for elevated glucose | ≥5.6 mmol/L or on treatment for elevated glucose |
| Triglycerides (TG) | ≥1.7 mmol/L | ≥1.7 mmol/L or on treatment for TG | ≥1.7 mmol/L or on treatment for TG | ≥1.7 mmol/L or on treatment for TG |
| HDL-C | M < 1.03 mmol/L | M < 1.03 mmol/L | M < 1.03 mmol/L | M < 1.0 mmol/L |
|
| ||||
| Metabolic syndrome definitions | At least 3 RF | WC + 2 or more RF | At least 3 RF | At least 3 RF |
RF: risk factors.
Figure 1The Cardiovascular Risk Prevention Study (CRisPS) sites map.
Demographic characteristics of the study subjects.
| Demographic characteristics | |
|---|---|
| All subjects, | 8836 (100) |
| Mean age in years (±SD) | 53.21 (±10.6) |
| Location, | |
| Urban | 4757 (53.8) |
| Rural | 4079 (46.2) |
| Gender, | |
| Male | 3766 (42.6) |
| Female | 5070 (57.4) |
| Ethnic group, | |
| Malays | 6408 (72.5) |
| Chinese | 1085 (12.3) |
| Indians | 280 (3.2) |
| Indigenous groups | 1063 (12.0) |
| Education attainment, | |
| No formal education | 1227 (14.7) |
| Primary | 2182 (26.1) |
| Secondary | 3236 (38.7) |
| Tertiary | 1715 (20.5) |
*Number not equal to n = 8836 due to missing data (n = 8360).
The overall and age-adjusted prevalence of metabolic syndrome according to the NCEP-ATP III, IDF, and JIS definitions by location, gender, ethnic group, and education attainment.
| Demographic characteristics | Total number of subjects | NCEP-ATP III (2001) | IDF (2005) | JIS (2009) |
|---|---|---|---|---|
| Prevalence (95% confidence interval) | ||||
| Overall | 8836 | 26.5 (25.6–27.4) | 37.4 (36.3–38.4) | 43.4 (42.3–44.4) |
|
| <0.001* | |||
| Location | ||||
| Urban | 4757 | 25.0 (23.8–26.2) | 39.0 (37.7–40.4) | 44.6 (43.2–46.0) |
| Rural | 4079 | 28.5 (27.1–29.9) | 36.3 (34.8–37.7) | 42.5 (41.0–44.0) |
|
| 0.001* | 0.002* | 0.018* | |
| Gender | ||||
| Male | 3766 | 24.1 (22.7–25.4) | 36.1 (34.6–37.7) | 43.8 (42.3–45.4) |
| Female | 5070 | 28.9 (27.6–30.1) | 39.3 (38.0–40.6) | 43.9 (42.6–45.2) |
|
| <0.001* | 0.001* | 0.777 | |
| Ethnic group | ||||
| Malays | 6408 | 29.1 (28.0–30.2) | 40.2 (39.1–41.4) | 46.0 (44.8–47.1) |
| Chinese | 1085 | 15.4 (13.3–17.6) | 27.9 (25.3–30.5) | 33.4 (30.7–36.0) |
| Indians | 280 | 30.1 (25.3–34.9) | 50.8 (45.6–56.0) | 56.5 (51.4–61.7) |
| Indigenous groups | 1063 | 20.7 (18.5–23.2) | 26.3 (23.6–29.1) | 32.5 (29.6–35.4) |
|
| <0.001* | <0.001* | <0.001* | |
| Education attainment | ||||
| No formal education | 1227 | 25.4 (22.6–28.2) | 32.3 (29.2–35.4) | 39.8 (36.6–43.0) |
| Primary | 2182 | 29.4 (27.4–31.3) | 38.5 (36.4–40.5) | 44.4 (42.3–46.6) |
| Secondary | 3236 | 27.1 (25.5–28.8) | 39.4 (37.7–41.2) | 44.9 (43.1–46.7) |
| Tertiary | 1715 | 19.5 (17.4–21.6) | 35.3 (32.8–37.7) | 40.8 (38.3–43.4) |
|
| <0.001* | 0.03* | 0.362 | |
*P value < 0.05.
Factors associated with metabolic syndrome according to the ATP III, IDF, and JIS definitions among Malaysian adults ≥30 years of age.
| Metabolic syndrome definitions | NCEP-ATP III (2001) | IDF (2005) | JIS (2009) | |||
|---|---|---|---|---|---|---|
| Odds ratio |
| Odds ratio |
| Odds ratio |
| |
| Location | ||||||
| Urban | 1.00 | 1.00 | 1.00 | |||
| Rural | 1.06 (0.94–1.20) | 0.326 | 0.87 (0.79–1.02) | 0.086 | 0.89 (0.80–1.00) | 0.058 |
| Gender | ||||||
| Male | 1.00 | 1.00 | 1.00 | |||
| Female | 1.29 (1.17–1.44) | <0.001* | 1.19 (1.09–1.31) | <0.001* | 1.02 (0.93–1.12) | 0.616 |
| Age (years) | ||||||
| 30–39 | 1.00 | 1.00 | 1.00 | |||
| 40–49 | 1.39 (1.13–1.73) | <0.001* | 1.63 (1.35–1.97) | <0.001* | 1.56 (1.30–1.87) | <0.001* |
| 50–59 | 2.26 (1.83–2.79) | <0.001* | 2.72 (2.25–3.27) | <0.001* | 2.72 (2.27–3.25) | <0.001* |
| ≥60 | 2.34 (1.87–2.92) | <0.001* | 2.67 (2.18–3.26) | <0.001* | 3.08 (3.54–3.70) | <0.001* |
| Ethnicity | ||||||
| Malay | 1.00 | 1.00 | 1.00 | |||
| Chinese | 0.44 (0.36–0.53) | <0.001* | 0.53 (0.45–0.62) | <0.001* | 0.56 (0.49–0.66) | <0.001* |
| Indian | 1.02 (0.77–1.37) | 0.867 | 1.48 (1.14–1.92) | 0.003* | 1.54 (1.18–1.99) | <0.001* |
| Indigenous groups | 0.60 (0.50–0.72) | <0.001* | 0.56 (0.47–0.66) | <0.001* | 0.63 (0.54–0.73) | <0.001* |
| Education level | ||||||
| No formal education | 1.00 | 1.00 | 1.00 | |||
| Primary | 1.16 (0.99–1.37) | 0.067 | 1.34 (1.15–1.58) | <0.001* | 1.18 (1.01–1.37) | 0.029* |
| Secondary | 1.05 (0.89–1.25) | 0.544 | 1.25 (1.06–1.48) | 0.009* | 1.12 (0.96–1.31) | 0.147 |
| Tertiary | 0.77 (0.63–0.95) | 0.012* | 1.04 (0.86–1.27) | 0.673 | 0.92 (0.76–1.10) | 0.350 |
*P value < 0.05.
Sensitivity, specificity, and level of agreement for metabolic syndrome as defined by the NCEP-ATP III and JIS definitions against the IDF definition.
| Definitions | IDF | |||||
|---|---|---|---|---|---|---|
| No MetS | Yes MetS | Sensitivity | Specificity | Kappa index |
| |
| NCEP-ATP III | ||||||
| No MetS | 5194 (93.9%) | 1299 (39.3%) | 60.7% | 93.9% | 0.580 | <0.001* |
| Yes MetS | 337 (6.1%) | 2006 (60.7%) | ||||
| JIS | ||||||
| No MetS | 4981 (90.1%) | 19 (0.6%) | 99.4% | 90.1% | 0.867 | <0.001* |
| Yes MetS | 550 (9.9%) | 3286 (99.4%) | ||||
*P value < 0.05.